Dr. Nathan Hogaboom, PhD

Claim this profile

Kessler Foundation

Studies Spinal Cord Injury
Studies Rotator Cuff Injury
3 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.
Kessler Foundation

Clinical Trials Nathan Hogaboom, PhD is currently running

Image of trial facility.

Shockwave Therapy

for Chronic Knee Pain

This trial is testing a non-invasive treatment using sound waves to help people with knee arthritis who have not improved with standard treatments. The goal is to see if this new method can reduce pain and improve knee function better than current care options. Wearable long-duration low-intensity ultrasound is an emerging non-invasive and non-narcotic therapy for the daily treatment of musculoskeletal pain.
Recruiting1 award N/A6 criteria
Image of trial facility.

Shockwave Therapy

for Spinal Cord Injury

People with spinal cord injury (SCI) experience a host of secondary complications that can impact their quality of life and functional independence. One of the more prevalent complications is spasticity, which occurs in response to spinal cord damage and the resulting disruption of motor pathways. Common symptoms include spasms and stiffness, and can occur more than once per hour in many people with SCI. Spasticity can have a negative impact over many quality of life domains, including loss of functional independence, activity limitations, and even employment. Its impact on health domains is also pronounced, with many people who have spasticity reporting mood disorders, depression, pain, sleep disturbances, and contractures. Spasticity can interfere with post-injury rehabilitation and lead to hospitalization. There are many treatments for spasticity in this population. However, many do not have long-term efficacy, and, if they do, they are often pharmacological in nature and carry side effects that could limit function or affect health. The goal of this pilot, randomized-controlled study is to investigate the potential efficacy and safety of a non-invasive treatment with a low side effect profile, extracorporeal shockwave therapy (ESWT). ESWT has shown some benefits in people with post-stroke spasticity with no long term side effects. Thirty individuals with chronic, traumatic SCI will be recruited. Fifteen will be provided with ESWT while the other fifteen will be given a sham treatment. Clinical and self-report measures of spasticity and its impact on quality of life will be collected, as well as quantitative ultrasound measures of muscle architecture and stiffness. The ultimate goal of this pilot project is to collect the data necessary to apply for a larger randomized-controlled trial. Conducting a larger trial will allow for a more powerful estimation of safety and efficacy of ESWT as a treatment for spasticity in people with SCI.
Recruiting0 awards N/A6 criteria

More about Nathan Hogaboom, PhD

Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Nathan Hogaboom, PhD has experience with
  • Dexamethasone
  • Lipogems
  • Focused Extracorporeal Shockwave Therapy
  • Extracorporeal Shockwave Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Nathan Hogaboom, PhD specialize in?
Is Nathan Hogaboom, PhD currently recruiting for clinical trials?
Are there any treatments that Nathan Hogaboom, PhD has studied deeply?
What is the best way to schedule an appointment with Nathan Hogaboom, PhD?
What is the office address of Nathan Hogaboom, PhD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security